Fierce Pharma: Reputation A Top Priority When Picking Prescription Meds

Prescription paper and pills | We. Communications

A Pharma company's reputation Ranked As A Leading Factor in Physician Prescription Decisions, According to We.'s Latest Healthy reputation: More Than Medicine Report

Fierce Pharma, Jacqueline Renfrow, 1 March 2023

In “Healthy Reputation: More Than Medicine,” healthcare professionals displayed their desire for pharma to go beyond just functional characteristics of a medication to address the entire health experience. In an interview with Fierce Pharma, Stephanie Marchesi, President, Global Health shared findings from We.'s latest report. 

“As communicators, our instincts and anecdotal feedback have told us that corporate reputation is important. But now we have hard evidence of its impact, both as influencing prescribing decisions among HCPs as well as contributing to the bottom line for biotech and pharma companies,” explained Marchesi.

To learn more, read We.'s latest Brands in Motion Report "Healthy Reputation: More Than Medicine."

 

   Full Article

 

(Photo courtesy of Fierce Pharma - Getty/LIgorko)

Explore more

our clean energy future | we. communications client

Energy Market Authority Singapore Appoints We. Communications As Agency of Record

Someone walking through a field with illustrated arrows and lines | We. Communications

Elastic Hands Integrated Comms Remit to We. Communications

Stephen Robertson headshot | We. Communications

WATATAWA Appoints New Managing Director

Group of communications leaders from We. Communications and Chase Advisors

Earned First: “We Are All Responsible”—AI in Healthcare Roundtable

Empty text blurb surrounded by digital icons

BW Marketing: What Every CEO Needs to Know About Communications in 2026

Illustration of a megaphone | We. Communications

Future of Communications: Grabbing Hearts Not Eyeballs